Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2347${count})

  • MJFF Research Grant, 2012
    Targeting the Unfolded Protein Response (UPR) Transcription Factor XBP1 to Alleviate Neurodegeneration Triggered by Alpha-synuclein

    Objective/Rationale: 
    Our general aim is to investigate the role of a specific component of a cellular stress response, known as the Unfolded Protein Response, in the development of Parkinson's disease...

  • MJFF Research Grant, 2012
    Mechanisms of Cellular Regulation and Post-translational Modification of LRRK2

    Promising Outcomes of Original Grant:
    We have identified methods to increase or decrease the ratio of cytosolic LRRK2 compared to membrane-localized LRRK2 as well as methods to increase or decrease the...

  • Research Grant, 2012
    Phase I-B Clinical Trial of AVE8112 for Cognitive Impairment in Parkinson’s Disease

    Objective/Rationale:
    Cognitive impairment is a symptom seen in Parkinson’s disease (PD) patients, and some can progress to dementia. AVE8112 is a PDE4 inhibitor that was in development by the...

  • Target Validation, 2012
    Targeting the JAK/STAT Pathway in the Treatment of Parkinson's Disease

    Objective/Rationale: 
    Parkinson’s disease (PD) involves inappropriate activation of the immune system.  Cytokines activate immune cells by engaging the JAK/STAT pathway, which receives signals from...

  • MJFF Research Grant, 2012
    The Role of Amyloid in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study

    Objective/Rationale:             
    Dementia is a frequent and devastating non-motor complication of Parkinson's disease (PD). Although loss of dopamine producing brain cells play a role in cognitive...

  • Target Validation, 2012
    Evaluation of the Microtubule-Stabilizing Agent, Epothilone D, in Mouse Models of Parkinson's Disease

    Objective/Rationale:             
    Microtubules are critical components within nerve cells, where they serve as the “railroad” tracks upon which cellular cargo is transported up and down the length of...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.